SCHEMBL2279549

SCHEMBL2279549

Clc1ccc(-c2cc(Cl)c(Cl)c(Cl)c2Cl)cc1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 10/20 1.00
CYP1B1 Q16678 1/20 0.60
CYP3A4 P08684 1/20 0.43
DHFR P00374 1/20 0.42
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TP53 P04637 1/20 0.39
NOTUM Q6P988 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
PKM P14618 1/20 0.38
ALOX12 P18054 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
PTGER1 P34995 1/20 0.38
PTGER3 P43115 1/20 0.38
PTGER2 P43116 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29389344 1.00 AHR (1.00) AHRCYP1B1CYP3A4DHFRNPC1
SCHEMBL2282125 0.84 AHR (1.00) AHRCYP1B1DHFRNPC1RAB9A
SCHEMBL29497479 0.81 AHR (0.68) AHRCYP1B1DHFRMEN1HTT
SCHEMBL29373291 0.81 AHR (0.68) AHRCYP3A4ADORA1
SCHEMBL10084006 0.81 AHR (0.68) AHRCYP1B1DHFRMEN1HTT
SCHEMBL3342313 0.81 AHR (0.68) AHRCYP3A4ADORA1
SCHEMBL2905963 0.80 AHR (0.67) AHRCYP1B1CYP3A4
SCHEMBL30424972 0.80 AHR (0.67) AHRCYP1B1CYP3A4
SCHEMBL4459047 0.80 AHR (0.67) AHRCYP1B1DHFRNPC1RAB9A
SCHEMBL2277002 0.79 AHR (1.00) AHRCYP1B1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4414356-A2 HIGHLY UNSATURATED FATTY ACID OR HIGHLY UNSATURATED FATTY ACID ETHYL ESTER WITH REDUCED ENVIRONMENTAL POLLUTANTS, AND METHOD FOR PRODUCING SAME Nissui Corporation (JP) 2024-08-14 EP claimed
EP-3971165-B1 HIGHLY UNSATURATED FATTY ACID OR HIGHLY UNSATURATED FATTY ACID ETHYL ESTER WITH REDUCED ENVIRONMENTAL POLLUTANTS, AND METHOD FOR PRODUCING SAME NISSUI CORP (JP) 2024-08-07 EP claimed
EP-2851361-B1 HIGHLY UNSATURATED FATTY ACID OR HIGHLY UNSATURATED FATTY ACID ETHYL ESTER WITH REDUCED ENVIRONMENTAL POLLUTANTS, AND METHOD FOR PRODUCING SAME NIPPON SUISAN KAISHA LTD (JP) 2021-11-24 EP claimed
EP-3881907-A1 METHOD FOR DECHLORINATION OF ONE OR MORE AROMATIC ORGANOCHLORINE COMPOUND(S) CONTAINED IN AN OIL OR FORMING SAID OIL - ASSOCIATED ELECTRICAL/ELECTRONIC DEVICE AND INSTALLATION Université de Lille (FR) 2021-09-22 EP claimed
US-6204005-B1 ACCURATE AND SENSITIVE QUALITATIVE OR QUANTITATIVE ANALYSIS BY INCUBATING ANTIBODIES AND COMPETITOR OF DEFINED STRUCTURE IN PRESENCE OF TEST SAMPLE, THEN DETECTING CONGENER ECOCHEM RESEARCH, INC. 2001-03-20 US claimed
US-5854010-A Bioassay for detecting 2,3,7,8-tetrachlorodibenzo-para-dioxin and TCDD-like compounds and novel recombinant cell line useful therefor XENOBIOTIC DETECTION SYSTEMS INTERNATIONAL, INC. 1998-12-29 US claimed
US-20250243146-A1 HIGHLY UNSATURATED FATTY ACID OR HIGHLY UNSATURATED FATTY ACID ETHYL ESTER WITH REDUCED ENVIRONMENTAL POLLUTANTS, AND METHOD FOR PRODUCING SAME NISSUI CORPORATION (JP) 2025-07-31 US disclosed
US-12331015-B2 Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same NISSUI CORPORATION (JP) 2025-06-17 US disclosed
US-20240226160-A9 ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE (US) 2024-07-11 US disclosed
US-20240131072-A1 ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE (US) 2024-04-25 US disclosed
EP-4291571-A2 ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN Seattle Children's Hospital d/b/a Seattle Children's Research Institute (US) 2023-12-20 EP disclosed
US-20230322925-A1 PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS SEATTLE CHILDREN’S HOSPITAL DBA SEATTLE CHILDREN’S RES INSTITUTE (US) 2023-10-12 US disclosed
CN-113535678-B Construction method of surface water environment priority pollutant list 中国科学院南京地理与湖泊研究所 2023-08-11 CN disclosed
EP-1489420-A1 INSTRUMENTS FOR DETECTING LOW-MOLECULAR WEIGHT SUBSTANCE Enbiotec Laboratories Co., Ltd. (JP) 2004-12-22 EP disclosed
US-20040241871-A1 Method and apparatus for analyzing endocrine-distrupting substances in vital sample SHOWA DENKO K.K. (JP) 2004-12-02 US disclosed
US-6720431-B2 SOLVENT EXTRACTION XENOBIOTIC DETECTION SYSTEMS INTERNATIONAL, INC. 2004-04-13 US disclosed
US-6469187-B1 PREPARATION OF FISH OIL WITH REDUCED PCBS BY A PROCESS OF COLD CLEARING, MIXING WITH ACTIVATED CHARCOAL UNDER REDUCED PRESSURE AND FILTRATION MERCK PATENT GMBH (DE) 2002-10-22 US disclosed
EP-1084214-A1 CONTAMINANT REDUCED MARINE OIL MERCK PATENT GmbH (DE) 2001-03-21 EP disclosed
WO-1999064547-A1 CONTAMINANT REDUCED MARINE OIL MERCK PATENT GMBH (DE) 1999-12-16 WO disclosed
US-5854010-A Bioassay for detecting 2,3,7,8-tetrachlorodibenzo-para-dioxin and TCDD-like compounds and novel recombinant cell line useful therefor XENOBIOTIC DETECTION SYSTEMS INTERNATIONAL, INC. 1998-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322925-A1 PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS PHOSPHO1, LCAT, CD47 AHR 765/4885CYP1B1 4745/4885CYP3A4 4045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.